Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article



Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.

Ashok Jaiswal.

Cited by (1)

Abstract
The prevalence of cardiovascular diseases is rapidly rising. In India, coronary artery disease is one of the leading causes of death. Evidence based guidelines are recommending multiple drug therapy (statins, aspirin, ACE-I and beta-blockers) for the prevention of CAD. Clinical data for the secondary prevention of CAD are endorsing significant mortality benefits with these evidence based therapy. In real life clinical practice, there is inadequacy of prescription for these evidence based poly-pharmacotherapy for the prevention of CAD. Further, chronic poly-pharmacotherapy is associated with poor adherence to the treatment. This poor adherence to the chronic preventive therapy has been found to be one of the major indicators for poor clinical outcome. Various clinical studies have established that FDC are associated with better patients’ compliance which can translate into better clinical outcome.

Key words: Coronary artery disease, Pollypill, Aspirin



Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

SYNGR4 and PLEKHB1 deregulation in motor neurons of amyotrophic lateral sclerosis models: potential contributions to pathobiology.
Marques RF, Duncan KE
Neural regeneration research. 2022; 17(2): 266-270

The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease.
Wang J, Zhang XN, Fang JN, Hua FF, Han JY, Yuan ZQ, Xie AM
Neural regeneration research. 2022; 17(4): 898-904


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites